Login to Your Account



Sareum Inks Deal with Hebei to Develop AML Drugs

By Cornelia Zou
Staff Writer

Wednesday, December 4, 2013

HONG KONG – A leading UK-based cancer drug developer and a Chinese university research institute have announced plans to work together to develop a new leukemia drug that may have a number of other uses.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription